Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP

被引：3
|
作者：
Adams, Hugo J. A. [1 ]
Kwee, Thomas C. [2 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol Nucl Med & Mol Imaging, Groningen, Netherlands
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 185卷 / 04期
关键词：
FDG-PET; Hodgkin lymphoma; POSITRON-EMISSION-TOMOGRAPHY;
D O I：
10.1111/bjh.15602
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：758 / 760
页数：3
相关论文
共 50 条
  • [1] Controversies on the prognostic value of interim FDG-PET in advanced-stage Hodgkin lymphoma
    Adams, Hugo J. A.
    Kwee, Thomas C.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (06) : 491 - 498
  • [2] RESPONSE ASSESSMENT AFTER 4 CYCLES OF BEACOPP USING FDG-PET IN PATIENTS WITH ADVANCED-STAGE HODGKIN LYMPHOMA
    Markova, J.
    Kobe, C.
    Skopalova, M.
    Dedeckova, K.
    Mocikova, H.
    Klaskova, K.
    Kahraman, D.
    Dietlein, M.
    Kozak, T.
    ANNALS OF ONCOLOGY, 2011, 22 : 160 - 160
  • [3] Response assessment after 4 cycles of beacopp using FDG-PET in patients with advanced-stage hodgkin lymphoma
    Markova, J.
    Kahraman, T. D.
    Kobe, C.
    Skopalova, M.
    Dedeckova, K.
    Gaherova, L.
    Dietlein, M.
    Kozak, T.
    ONKOLOGIE, 2011, 34 : 132 - 132
  • [4] Early FDG-PET scan in advanced stage Hodgkin lymphoma treated with BEACOPP-14
    Rubio-Martinez, A.
    Alvarez, R.
    Garcia-Miralles, M.
    Gaston, R.
    Giraldo, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 471 - 472
  • [5] Early interim FDG-PET overshadows the prognostic role of IPS in advanced-stage Hodgkin lymphoma treated by conventional ABVD therapy
    Gallamini, A.
    Hutchings, M.
    Rigacci, L.
    Specht, L.
    Merli, F.
    Hansen, M.
    Patti, C.
    Loft, A.
    Di Raimondo, F.
    D'Amore, F.
    Biggi, A.
    Vitolo, U.
    Stelitano, C.
    Sancetta, R.
    Trentin, L.
    Luminari, S.
    Iannitto, E.
    Viviani, S.
    Pierri, I.
    Levis, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 32 - 32
  • [6] Does interim PET increase the value of ABVD in advanced-stage Hodgkin lymphoma?
    Gallamini, A.
    Kostakoglu, L.
    ANNALS OF ONCOLOGY, 2015, 26 (06) : 1045 - 1047
  • [7] Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma
    Kobe, Carsten
    Goergen, Helen
    Baues, Christian
    Kuhnert, Georg
    Voltin, Conrad-Amadeus
    Zijlstra, Josee
    Hoekstra, Otto
    Mettler, Jasmin
    Drzezga, Alexander
    Engert, Andreas
    Borchmann, Peter
    Dietlein, Markus
    BLOOD, 2018, 132 (21) : 2273 - 2279
  • [8] EARLY CHEMOTHERAPY INTENSIFICATION WITH BEACOPP IN HIGH-RISK, INTERIM-PET POSITIVE, ADVANCED-STAGE, ABVD-TREATED HODGKIN LYMPHOMA PATIENTS
    Fiore, F.
    Patti, K.
    Viviani, S.
    Rossi, A.
    Di Raimondo, F.
    Cantonetti, M.
    Stelitano, C.
    Feldman, T.
    Gavarotti, P.
    Sorasio, R.
    Biggi, A.
    Barrington, S.
    Gallamini, A.
    HAEMATOLOGICA, 2010, 95 : S22 - S22
  • [9] The role of FDG-PET in early therapy assessment and follow-up of patients with advanced Hodgkin Lymphoma treated with BEACOPP
    Kahraman, D.
    Markova, J.
    Kobe, C.
    Skopalova, M.
    Mocikova, H.
    Klaskova, K.
    Dedeckova, K.
    Eich, H.
    Boell, B.
    Dietlein, M.
    Kozak, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S251 - S251
  • [10] Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma
    Adams, Hugo J. A.
    Kwee, Thomas C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (01) : 129 - 131
12345